Altogether, our findings showed that the HMGB1-induced Drp1-dependent mitochondrial dynamics via RAGE-ERK signaling pathway for autophagy and chemoresistance could be candidate therapeutic targets for new treatment strategies in colorectal cancer. Here, MAPK1 is linked to colorectal cancer.